Weight loss efficacy of tirzepatide compared to placebo or GLP-1 receptor agonists in adults with obesity or overweight: A meta-analysis of randomized controlled trials with 20 weeks treatment duration
Head and neurological effects Tirzepatide headaches are common in the first few weeks and often reflect dehydration more than direct medication effects
(Article in Japanese) Sakurabayashi T, Takaesu Y, Haginoshita S, et al
[52] Pereira de Arruda EH, Vieira da Silva GL, da Rosa-Santos CA, et al
Several studies demonstrate that Ex4 and liraglutide reduce heroin- and oxycodone-seeking behavior, particularly under reinstatement paradigms triggered by drug-associated cues or priming
A 2021 clinical trial that tested the weight loss effects of Wegovy found that while about 40% of the weight people lost tended to be lean mass, including muscle, at the end of 68 weeks, people who took the drug had a lower risk of heart disease and better physical function compared to a placebo group